Valley Ready
Want to build a network in Silicon Valley? Looking to commercialize in the US?
Applications will be open for Fall 2026 cohort early next year!
About CELS Valley Ready
The CELS Valley Ready (VR) program is a curated, high-impact experience that connects scaling founders like you with U.S. investors, seasoned mentors, and sector-specific experts and champions, all while helping you sharpen your pitch, deepen your network, and build a roadmap for market success.
This isn’t a one-size-fits-all accelerator, it’s a curated growth experience built for high-potential companies ready to scale in the U.S.
What You’ll Gain
Dedicated Mentorship: One-on-one guidance from a senior industry mentor throughout the program.
Targeted Expert Support: Personalized introductions to domain experts and champions based on the cohort's areas of need (e.g., FDA, reimbursement, IP, fundraising).
Real-Time Feedback: Early pitch sessions with investors or mentors to help tailor your fundraising strategy.
Custom-Curated Content: GTM workshops and custom roundtables designed around your company’s specific challenges and growth stage.
Peer Learning Streams: Opportunities to connect with like-minded founders by subsector (therapeutics, diagnostics, devices).
In-Person Immersion: Two days in San Francisco, that includes 1:1 investor meetings, workshops, and networking, including a ticket to our annual Charter Member dinner.
Annual Showcase: Each company receives one ticket to attend our annual Canada in the Valley Showcase. This includes two days of speakers, executive roundtables, 1:1 investor meetings and a networking reception.
EXPLORE CELS THROUGH OUR INFO SESSION
Learn more about CELS, our Valley Ready program, and other ways to connect into Silicon Valley for capital and other strategic connections. View dates and RSVP below.
Fall 2025 Participating Companies
-
![Aufero Medical]()
Aufero Medical
Aufero Medical develops TruContact, a robotic stabilization tool for cardiac ablation catheters that enhances treatment effectiveness by improving catheter contact during procedures, aiming to democratize advanced electrophysiology therapy.
-
![Integrated Nanotherapeutics]()
Integrated Nanotherapeutics
They are retraining the immune system to stop attacking healthy cells through antigen-specific immune tolerance.
-
![Kare Chemical Technologies]()
Kare Chemical Technologies
Developing novel cannabinoids by derivatizing phytocannabinoids which we can make synthetically as new pharmaceutical treatments for pain and obesity.
-
![NovusTX Devices]()
NovusTX Devices
Patient-Friendly & Surgery-Free Neurostimulation for Parkinson's Disease and Essential Tremor
-
![Qualisure Diagnostics]()
Qualisure Diagnostics
Qualisure Diagnostics is building a high-margin precision oncology business by commercializing validated molecular diagnostics and a scalable cloud platform that decentralizes test deployment and unlocks a global diagnostics marketplace.
-
![Rewire Digital Therapeutics]()
Rewire Digital Therapeutics
Rewire DTx is building the brain health platform of the future: FDA-integrated, neuroscience-based mobile games that treat conditions like anger and chronic pain by repairing and strengthening neural pathways
-
![Tarkka Manufacturing Solutions]()
Tarkka Manufacturing Solutions
Tarkka is a patent-protected advanced materials manufacturer that transforms wheelchair seating from weeks-long processes to single-visit solutions, delivering the only complete system addressing pressure, hygiene, durability, and positioning through proprietary Tetrx™ composites and trainable mass customization.
Program Timeline & Workshops
-
- Program Kick-off
- Founders Journey
- Best Practices When Raising Capital from U.S. Investors
-
- Human Capital - how to elevate key executive roles, advisors and outsourcing or fractional roles
- Corporate Strategy: How to build value in your company on a shoestring budget
- How to incorporate AI into your executive toolbox
- IP and Patent Consideration with US Expansion
-
- Setting up a business in the US
- Understanding Cross Border Taxes
- How to Effectively Manage Your Board
- In-market 2-days of programming
- Corporate Structure & U.S. Considerations
- Growing Your Executive Presence
- Wrap Up & Graduation
Past Participating Program Speakers, Mentors & Investors
-
Michael Leung
Co-founder & COO
Spect Inc.
-
Ritish Patnaik
CEO and Co-Founder
Curve Biosciences
-
![]()
Angele Maki
Chief Business Officer
Hummingbird BioScience
-
![Alex Mok]()
Alex Mok
Founder/CEO
Mantra Bio
-
![Rami Hannoush]()
Rami Hannoush
Partner
Versant Ventures
-
![]()
Scott St. Germain
Vice President and Flu Business General Manager
Genentech
-
![Ali Samiaan]()
Ali Samiaan
Founder
Poplar Access Advisors
-
Qing Zhang
Partner
LDV Partners
-
Hicham Alaoui
Chief Scientific Officer
Glycomine Inc.
-
Corey Zankowski
Founder & CEO
Amplifai Oncology
-
Mark Arundine
Business Development Head
Genentech
-
JC Simbana
Managing Director
Customers Bank
-
Michael Maszy
Chair
The Band of Angels
-
Shiva Amiri
Partner, VP - Head of Data and AI
Pivotal Life Sciences
-
![]()
Dongxue Wang
Corporate venture investor/clinical researcher
GUDU MEDICAL PTE.LTD/UCSF
-
Arnold Lee
General Partner
Sugati Ventures
-
![]()
Gilly Regev
Co-Founder, Director
SaNOtize
-
![Richard McDerby]()
Richard McDerby
Partner
Manatt Ventures
-
Michel Narganes
Partner
Manatt Ventures
-
![]()
Hamid Farzaneh
Partner
Bridge 2
-
![]()
Bassam El-Fahmawi
President & Chief Technical Officer
Mawi DNA Technologies
-
![]()
Cedric Bisson
Partner
Teralys Capital
-
Qing Zhang
Partner
LDV Partners
-
![]()
Seiya Takahashi
Venture Partner
Hike Ventures
-
![]()
Marlene Grenon
Venture Partner
IA Seed Ventures
-
David Schuster
Managing Partner
UpScalerVC
-
Charline Kempter
Trade Attaché
Quebec Trade Office in Silicon Valley
-
![]()
Tom Vogelsong
Startup Scout
K2X Technology and Life Science
-
![Alicia Chung]()
Alicia Chung
Venture Advisor
Magnet Ventures
-
![Mike Henry]()
Mike Henry
Chief Business Officer
Aldatu Biosciences
-
![Nicolas Saint-Arnaud]()
Nicolas Saint-Arnaud
Co-founder, Engineering Lead
SURUDO
-
![Soyoung Park]()
Soyoung Park
General Partner
1004 Venture Partners
-
![]()
Ajit Singh
Managing Director and General Partner
Artiman Ventures
-
![]()
Alex Efron
Healthcare & Life Sciences Investor
Telegraph Hill Partners
-
![]()
Bassam El-Fahmawi
President & Chief Technical Officer
Mawi DNA Technologies
-
![]()
Tom Vogelsong
Angel Investor, Life Science & Tech Advisor
K2X Capital
-
![]()
Scott St. Germain
Vice President and Flu Business General Manager
Genentech
-
![]()
Gloria Maceiko
Managing Director and Founder
Silicon Valley Advantage
-
![]()
Cheryl Reicin
Partner
Mintz
-
![]()
Humphrey Polanen
CEO and Board Chair
Deep Medicine Acquisition Corp
-
![]()
Mark Mitchell
Senior Director, R&D Finance
Alexion Pharmaceuticals
-
![]()
Oguzhan Atay
Co-founder & CEO
BillionToOne
-
![]()
Tarek El-Sawy
Venture Capital Partner
Raiven Capital
Testimonials
-
![]()
“I think the network that CELS brings to the Valley Ready program, and the caliber of the experts that lead the workshops, was incredible. Our companies received a lot of value from the program and I encourage all life science companies looking to scale beyond Canada to apply.”
Sandra, UofA Health Hub
-
![]()
“I wasn't sure what to expect when we joined CELS, but I wasn't disappointed! The quality of companies in the cohort was excellent and the insight provided via the workshops outstanding. The program covers a lot of ground, as it accommodates startups across their journey.”
John, StreamML
-
![]()
"The Showcase speakers were inspiring and the connections phenomenal. We’ve participated in several accelerators and the CELS Valley Ready program truly brings meaningful connections for companies looking to raise capital and scale in the U.S."
Mike, AmacaThera
-
![]()
“We made some fantastic connections and the Valley Ready program was excellent for companies like ours looking to expand our geographical scope to the U.S.”
Chris, Inteligex
-
![]()
“The mentors are one of the best aspects of the Valley Ready program, as CELS connects you with the right person who understands your business and science.”
Lina, Factually Health
